Emphysema Fibrosis Detection
Emphysema Fibrosis Detection - Related Videos
04:14
Masson Goldner Trichrome Staining: A Technique to Visualize Collagen in Heart Sections for Cardiovascular Fibrosis Detection
0 Views •
2025
This video demonstrates the differential staining of collagen fibers, nuclei, and cytoplasm in heart tissue to visualize fibrotic growth associated with cardiac pathologies.
01:23
Chronic Obstructive Pulmonary Disease II: Emphysema
0 Views •
2026
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
09:27
The Dimethylnitrosamine Induced Liver Fibrosis Model in the Rat
0 Views •
Cited by 11 •
2016
We describe a method to produce an animal model of liver fibrosis in the rat, and assess the degree of fibrosis by histological examination of the liver. The model can be used to study the development of liver disease as well as to test the efficacy of potential anti-fibrotic agents.
02:49
Picrosirius Red Polarization Staining: A Technique To Detect Fibrosis in Cardiac Tissue Sections Using Bright-Field Microscopy
0 Views •
2025
This video describes the picrosirius red staining of fibrotic tissues to detect excessive collagen deposition in fibrotic tissue sections. The staining technique helps assess collagen expression in connective-tissue diseases.
01:23
Cystic Fibrosis: Pathogenesis
0 Views •
2024
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body. CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
FAQs
The analysis compares structural features rather than relying on a single abnormality. Emphysema-related injury is indicated by changes in air-space size and loss of alveolar-wall organization, whereas fibrosis is evaluated through increased connective-tissue deposition, altered density, and architectural stiffness. Examining these features together helps classify the dominant pattern of lung remodeling and separate different forms of chronic injury.
Architectural organization provides context for individual measurements such as air-space size, density, and texture. A change in one feature may have different significance depending on how surrounding tissue is arranged. Evaluating the overall structure therefore supports more reliable characterization of injury, because it links measurable abnormalities with the way chronic damage remodels the lung.
Detection findings can be interpreted within a biological sequence in which chronic injury and inflammation contribute to tissue remodeling. Damage may be reflected as loss of normal alveolar structure or accumulation of connective tissue, while the resulting architectural changes help explain impaired gas exchange. This connection allows structural measurements to inform studies of disease mechanisms, not only classification.
A typical workflow begins by selecting lung regions for analysis, then examining them with imaging or tissue-based methods. Measurements of air-space size, density, texture, and architectural organization are compared with the appearance of healthy tissue. The resulting pattern is classified and may be related to severity, progression, or treatment response, depending on the research question.
The source describes imaging and tissue examination as complementary ways to analyze lung structure, but it does not assign them fixed situations or advantages. The choice can therefore depend on the study design and the structural information required. Imaging or tissue measurements may be selected to evaluate air spaces, density, texture, connective-tissue changes, or overall architecture.
These measurements can help classify the pattern of lung injury, estimate disease severity, and track progression over time. They also provide structural outcomes for evaluating responses to treatment. In broader pulmonary research, the findings support comparisons between injured and healthy tissue and help investigators examine how remodeling relates to impaired gas exchange and chronic disease mechanisms.